MARJORIE TORRES: Open Payments
NPI 1710425004 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 7 payments from 5 companies in 2025. Trend: 2023 $55 · 2024 $422 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Teva Pharmaceuticals USA, Inc. | 1 | $107 |
| Alpha Cognition USA, Inc. | 2 | $62 |
| UCB, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: AUSTEDO XR, Zunveyl, Briviact, Fintepla, REXULTI.
Industry payments across LA — which companies pay providers there.
